Skip to main content

Table 2 CNS-active medications per resident at baseline and follow-up

From: Engagement is a necessary condition to test audit and feedback design features: results of a pragmatic, factorial, cluster-randomized trial with an embedded process evaluation

CNS-active medications per resident

Trial arm 1

Median comparator & benefit framing

Trial arm 2

Top quartile comparator & benefit framing

Trial arm 3

Median comparator & risk framing

Trial arm 4

Top quartile comparator & risk framing

Baseline

n residents

2817

3277

3768

2725

Mean ± SD

1.12 ± 1.04

1.26 ± 1.10

1.07 ± 1.04

1.10 ± 1.07

At 6 months

n residents

2904

3334

3989

2744

Mean ± SD

1.13 ± 1.02

1.28 ± 1.10

1.06 ± 1.02

1.10 ± 1.07